FindTrial
Sign In

Evaluation of the advantage of variable SVV by cardiopulmonary ultrasound in perioperative target-directed fluid therapy in ARDS patients

Evaluation of the advantage of variable SVV by cardiopulmonary ultrasound in perioperative target-directed fluid therapy in ARDS patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026664
Enrollment
Unknown
Registered
2019-10-17
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Interventions

Control:CVP monitor
Experimental group:SVV monitor

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Severe craniocerebral trauma combined with ARDS who underwent craniotomy hematoma evacuation in Xuzhou Central Hospital were enrolled

Exclusion criteria

Exclusion criteria: Any contraindication to fluid resuscitation, such as congestive heart failure or evidence of fluid overload; pregnant women; patients with cerebrovascular accident; conditions which could affect SVV and cardiopulmonary ultrasound measuring, such as pneumothorax, arrhythmia, abdomen visceral rupture were excluded from the study.

Design outcomes

Primary

MeasureTime frame
CVP;SVV;fluid intake;blood pressure;—

Secondary

MeasureTime frame
mortality;ICU stay time;—

Countries

China

Contacts

Public ContactWang Kai

Xuzhou Central Hospital

wangkaistream99@sina.com+86 18112012729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026